NEWARK, Del,. April 4, 2012 /PRNewswire/ -- iBio, Inc. (NYSE AMEX: IBIO) today announced issuance of a US patent covering compositions and methods for generating clonal cell lines and plants for expressing gene products. This invention, developed by the Fraunhofer USA Center for Molecular Biotechnology, iBio’s research collaborator, is a part of iBio’s broader iBioLaunch™ platform for vaccines and therapeutics. The new patent is US Patent 8,148,608 entitled “Systems and methods for clonal expression in plants.” |
|
aus der Diskussion: | iBio - Die Impfstoffmaschine |
Autor (Datum des Eintrages): | lunatics (09.04.12 10:49:39) |
Beitrag: | 6 von 18,242 (ID:43015166) |
Alle Angaben ohne Gewähr © wallstreetONLINE |